Effective for dates of service on or after January 1, 2018, the Centers for Medicare and Medicaid Services (CMS) has granted BESPONSA™ (inotuzumab ozogamicin) injection for IV infusion the following temporary Healthcare Common Procedure Coding System (HCPCS) C-Code*:

 C9028 – injection, inotuzumab ozogamicin, 0.1 mg

This update is about an important coding change for BESPONSA.   Additionally, patients receiving BESPONSA, and their providers, have access to Pfizer Oncology Together, a program that provides support to help patients get their medication, including financial assistance, treatment support, and resources to navigate potential insurance and coverage issues. Resources are available by calling 1-877-744-5675 or at

Full Prescribing Information for BESPONSA:

No comments have been posted yet.